Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Sato

Showing results (11-20 of 301) with videos related to

Pageof 31
Sort By:
Statistics in Medicine|May 26, 2016
An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trialsHiroyuki Sato, Akihiro Hirakawa, Chikuma Hamada
International Journal of Cancer|December 15, 2005
Development of multidrug resistance due to multiple factors including P-glycoprotein overexpression under K-selection after MYC and HRAS oncogene activationYukari Nakamura, Hiroyuki Sato, Toru Motokura
Cancer Letters|June 28, 2005
Differential 14-3-3 sigma DNA methylation and expression in c-myc- and activated H-ras-transformed cells under r- and K-selectionHiroyuki Sato, Yukari Nakamura, Toru Motokura
The Journal of Dermatology|January 6, 2009
Two cases of subungual melanoma in situSumihisa Imakado, Hiroyuki Sato, Kazutoshi Hamada
BMC Cancer|November 27, 2007
Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignanciesToru Motokura, Yukari Nakamura, Hiroyuki Sato
Cancer Medicine|June 7, 2026
Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer-Based Health Insurance Claims DataRisa Murakami, Hiroyuki Sato, Akihiro Hirakawa
Journal of Gastroenterology|March 2, 2002
Detection of type B influenza virus genes from biopsied gastric mucosaYukiharu Hayase, Kiyotake Tobita, Hiroyuki Sato
Pharmaceutical Statistics|August 20, 2016
Effect of design specifications in dose-finding trials for combination therapies in oncologyAkihiro Hirakawa, Hiroyuki Sato, Masahiko Gosho
Biophysics (Nagoya-Shi, Japan)|August 6, 2016
Full-Quantum chemical calculation of the absorption maximum of bacteriorhodopsin: a comprehensive analysis of the amino acid residues contributing to the opsin shiftTomohiko Hayashi, Azuma Matsuura, Hiroyuki Sato, et al.
International Journal of Medical Informatics|February 14, 2026
Applying a statistical model-based AI method to identify prognostic factors for long-term cognitive decline in Alzheimer's disease: Evidence from pooled placebo data of four phase III trialsRyoichi Hanazawa, Hiroyuki Sato, Keisuke Suzuki, et al.
Pageof 31

Showing results (11-20 of 301) with videos related to

Sort By:
Pageof 31
Statistics in Medicine|May 26, 2016
An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trialsHiroyuki Sato, Akihiro Hirakawa, Chikuma Hamada
International Journal of Cancer|December 15, 2005
Development of multidrug resistance due to multiple factors including P-glycoprotein overexpression under K-selection after MYC and HRAS oncogene activationYukari Nakamura, Hiroyuki Sato, Toru Motokura
Cancer Letters|June 28, 2005
Differential 14-3-3 sigma DNA methylation and expression in c-myc- and activated H-ras-transformed cells under r- and K-selectionHiroyuki Sato, Yukari Nakamura, Toru Motokura
The Journal of Dermatology|January 6, 2009
Two cases of subungual melanoma in situSumihisa Imakado, Hiroyuki Sato, Kazutoshi Hamada
BMC Cancer|November 27, 2007
Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignanciesToru Motokura, Yukari Nakamura, Hiroyuki Sato
Cancer Medicine|June 7, 2026
Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer-Based Health Insurance Claims DataRisa Murakami, Hiroyuki Sato, Akihiro Hirakawa
Journal of Gastroenterology|March 2, 2002
Detection of type B influenza virus genes from biopsied gastric mucosaYukiharu Hayase, Kiyotake Tobita, Hiroyuki Sato
Pharmaceutical Statistics|August 20, 2016
Effect of design specifications in dose-finding trials for combination therapies in oncologyAkihiro Hirakawa, Hiroyuki Sato, Masahiko Gosho
Biophysics (Nagoya-Shi, Japan)|August 6, 2016
Full-Quantum chemical calculation of the absorption maximum of bacteriorhodopsin: a comprehensive analysis of the amino acid residues contributing to the opsin shiftTomohiko Hayashi, Azuma Matsuura, Hiroyuki Sato, et al.
International Journal of Medical Informatics|February 14, 2026
Applying a statistical model-based AI method to identify prognostic factors for long-term cognitive decline in Alzheimer's disease: Evidence from pooled placebo data of four phase III trialsRyoichi Hanazawa, Hiroyuki Sato, Keisuke Suzuki, et al.
Pageof 31